AttendMe Owl Logo
AttendMe
Evidence Evolution
NeurosurgeryNeurosurgery

How This Evidence Evolved

Decompressive Craniectomy in Stroke

From observational benefit to age-stratified evidence and guideline integration

25.1

Timeline

Signal

Early observations and pilot data that first suggested a new direction

Malignant middle cerebral artery (MCA) infarction has been associated with mortality of up to 80%. An open prospective study treated 63 patients with hemicraniectomy. Overall, 46 patients (73%) survived. The study examined function and the timing of surgery, as well as survival. Early decompression could improve outcome, but randomized evidence was needed to assess the balance between survival and disability.
Proof

Landmark RCTs and pivotal trials that established the evidence base

The DECIMAL, DESTINY, and HAMLET trials supplied randomized evidence for decompressive surgery. A prospectively planned pooled analysis included 93 patients aged 18–60 years who were treated within 48 hours of stroke onset. At 1 year, survival was 78% with surgery versus 29% with control treatment. An mRS score of 0–4, the primary favorable-outcome definition, occurred in 75% versus 24%; an mRS score of 0–3 occurred in 43% versus 21%. DECIMAL stopped after slow recruitment. The findings support early surgery while making the degree of disability central to individual decisions.
Extension

Follow-up studies, subgroup analyses, and real-world validation

DESTINY II randomized 112 patients aged 61 years or older within 48 hours of symptom onset. At 6 months, survival without severe disability (mRS 0–4) was 38% with hemicraniectomy versus 18% with conservative treatment (odds ratio 2.91, 95% CI 1.06–7.49; P=0.04). Mortality was 33% versus 70%. No patient achieved mRS 0–2. Most survivors required assistance with bodily needs. These outcomes make survival and functional dependence central to discussions about surgery in older patients.
Guidelines

Integration into clinical practice guidelines and recommendations

The official AHA/ASA 2019 slide set states that decompressive craniectomy with dural expansion is reasonable for patients ≤60 years who deteriorate neurologically within 48 hours from brain swelling associated with unilateral MCA infarction despite medical therapy (Class IIa, Level A). For patients >60 years meeting the same deterioration criteria, surgery may be considered (Class IIb, Level B-R).
AHA/ASA
Now

Current standard of care and ongoing research directions

Decompressive surgery within 48 hours remains a clinical consideration for younger patients with malignant MCA infarction. The pooled randomized analysis studied ages 18–60 within that window. DESTINY-II studied ages 61 and older and found lower mortality, but most survivors required assistance with bodily needs. These different outcomes make pre-stroke function, survival, dependence and patient/family values central to decisions. HAMLET states that decisions should reflect the importance patients and relatives place on survival and dependency. Survival alone does not capture the full result of surgery.

Landmark Trials in This Story

Schwab 19981998

Early hemicraniectomy in patients with complete middle cerebral artery infarction

Survival: 46/63 (73%)

StrokeProspective cohortN=63
DECIMAL2007

Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial).

mRS ≤3 at 6 months: surgery 25% vs no surgery 5.6% (P=0.18)

StrokeMulticenter randomized controlled trialN=38
DESTINY2007Landmark

Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial

Modified Rankin Scale ≤3 at 6 months

StrokeRCTN=32
HAMLET2009Landmark

Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial

Modified Rankin Scale at 12 months

Lancet NeurolRCTN=64
Pooled Analysis2007Landmark

Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials

mRS 0–4 vs 5–6 at 1 year

Lancet NeurolPooled analysis of 3 RCTsN=93
DESTINY-II2014Landmark

Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke

Modified Rankin Scale 0-4 at 6 months (survival without severe disability)

New England journal of medicineRCTN=112
HeADDFIRST2014

Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial: randomized pilot clinical trial

Death at 21 days

StrokeRCTN=40

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.

Related Evidence

Frequently Asked Questions

What is the optimal timing for decompressive craniectomy in malignant MCA infarction?+
The pooled analysis included patients treated within 48 hours of stroke onset and found better survival and functional outcomes with surgery. HAMLET found no evidence of improved functional outcome when surgery was delayed for up to 96 hours. The decision should reflect the importance patients and relatives place on survival and dependency.
Should decompressive craniectomy be offered to patients over 60?+
DESTINY-II randomized patients aged 61 or older within 48 hours. At 6 months, mortality was 33% with surgery versus 70% with conservative care. No patient achieved mRS 0–2, and most survivors required help with bodily needs. The AHA/ASA 2019 slide set says surgery may be considered in patients >60 years who deteriorate neurologically within 48 hours from brain swelling associated with unilateral MCA infarction despite medical therapy (Class IIb, Level B-R). Patient values matter.
What functional outcomes can be expected after decompressive craniectomy?+
The pooled analysis included ages 18–60 treated within 48 hours. At 1 year, mRS 0–3 occurred in 43% with surgery versus 21% with control treatment; survival was 78% versus 29%. The primary favorable outcome used mRS 0–4, reached by 75% versus 24%. These thresholds describe different levels of disability, so counseling should discuss both survival and functional dependence.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Claims checked against cited sources: 10 November 2026